VERU INC. Effective Income Tax Rate Reconciliation, Deduction, Other, Amount
VERU INC. (VERU) reported Effective Income Tax Rate Reconciliation, Deduction, Other, Amount of $440.10 thousand for the 12-month period ending 2017-09-30, per its 10-K filed 2018-12-13.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationDeductionsOther · last filed 2018-12-13
- VERU INC. effective income tax rate reconciliation, deduction, other, amount for the quarter ending 2015-03-31 was $80.06K.
- VERU INC. effective income tax rate reconciliation, deduction, other, amount for the quarter ending 2014-12-31 was -$25.70K, a 112.54% decline year-over-year.
- VERU INC. effective income tax rate reconciliation, deduction, other, amount for the quarter ending 2014-09-30 was -$2.00K, a 100.75% decline year-over-year.
- VERU INC. effective income tax rate reconciliation, deduction, other, amount for the quarter ending 2014-06-30 was -$62.41K, a 111.36% decline year-over-year.
- VERU INC. effective income tax rate reconciliation, deduction, other, amount for fiscal 2017 was $440.10K.
- VERU INC. effective income tax rate reconciliation, deduction, other, amount for fiscal 2014 was -$24.55K, a 101.19% decline from fiscal 2013.
- VERU INC. effective income tax rate reconciliation, deduction, other, amount for fiscal 2013 was $2.07M, a 26.49% increase from fiscal 2012.
- VERU INC. effective income tax rate reconciliation, deduction, other, amount for fiscal 2012 was $1.64M, a 68.13% increase from fiscal 2011.
| Period end | Effective Income Tax Rate Reconciliation, Deduction, Other, Amount 3 month | Effective Income Tax Rate Reconciliation, Deduction, Other, Amount 3 month as first filed | Effective Income Tax Rate Reconciliation, Deduction, Other, Amount 6 month | Effective Income Tax Rate Reconciliation, Deduction, Other, Amount 9 month | Effective Income Tax Rate Reconciliation, Deduction, Other, Amount 9 month as first filed | Effective Income Tax Rate Reconciliation, Deduction, Other, Amount 12 month |
|---|---|---|---|---|---|---|
| 2017-09-30 | $440.10K 10-K · filed 2018-12-13 | |||||
| 2015-03-31 | $80.06K 10-Q · filed 2015-04-30 | $54.36K 10-Q · filed 2015-04-30 | $52.36K derived: sum of 3 quarters · filed 2015-04-30 | -$10.05K derived: sum of 4 quarters · filed 2015-04-30 | ||
| 2014-12-31 | -$25.70K 10-Q · filed 2015-02-03 | -$27.70K derived: sum of 2 quarters · filed 2015-02-03 | -$90.10K derived: sum of 3 quarters · filed 2015-02-03 | -$255.16K derived: sum of 4 quarters · filed 2015-04-30 | ||
| 2014-09-30 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-02 | -$64.41K derived: sum of 2 quarters · filed 2014-12-02 | -$229.47K derived: sum of 3 quarters · filed 2015-04-30 | -$24.55K 10-K · filed 2014-12-02 | ||
| 2014-06-30 | -$62.41K 10-Q · filed 2014-07-31 | -$227.47K derived: sum of 2 quarters · filed 2015-04-30 | -$22.56K 10-Q · filed 2014-07-31 | $244.56K derived: sum of 4 quarters · filed 2015-04-30 | ||
| 2014-03-31 | -$165.06K 10-Q · filed 2015-04-30 | $39.85K 10-Q · filed 2015-04-30 | $306.96K derived: sum of 3 quarters · filed 2015-04-30 | $856.51K derived: sum of 4 quarters · filed 2015-04-30 | ||
| 2013-12-31 | $204.91K 10-Q · filed 2015-02-03 | $125.98K 10-Q · filed 2014-02-03 | $472.03K derived: sum of 2 quarters · filed 2015-02-03 | $1.02M derived: sum of 3 quarters · filed 2015-02-03 | $1.71M derived: sum of 4 quarters · filed 2015-02-03 | |
| 2013-09-30 | $267.11K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-03 | $816.65K derived: sum of 2 quarters · filed 2013-12-03 | $1.51M derived: sum of 3 quarters · filed 2013-12-03 | $2.07M 10-K · filed 2013-12-03 | ||
| 2013-06-30 | $549.54K 10-Q · filed 2013-08-01 | $1.24M derived: sum of 2 quarters · filed 2013-08-01 | $1.80M 10-Q · filed 2013-08-01 | $1.30M derived: sum of 4 quarters · filed 2014-02-03 | ||
| 2013-03-31 | $689.01K 10-Q · filed 2013-05-02 | $1.25M 10-Q · filed 2013-05-02 | $752.81K derived: sum of 3 quarters · filed 2014-02-03 | $1.54M derived: sum of 4 quarters · filed 2014-02-03 | ||
| 2012-12-31 | $565.28K 10-Q · filed 2014-02-03 | $63.80K derived: sum of 2 quarters · filed 2014-02-03 | $848.02K derived: sum of 3 quarters · filed 2014-02-03 | $1.62M derived: sum of 4 quarters · filed 2014-02-03 | ||
| 2012-09-30 | -$501.48K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-03 | $282.74K derived: sum of 2 quarters · filed 2013-12-03 | $1.06M derived: sum of 3 quarters · filed 2013-12-03 | $1.64M 10-K · filed 2013-12-03 | ||
| 2012-06-30 | $784.22K 10-Q · filed 2013-08-01 | -$784.22K 10-Q · filed 2012-07-31 | $1.56M derived: sum of 2 quarters · filed 2013-08-01 | $2.14M 10-Q · filed 2013-08-01 | -$2.14M 10-Q · filed 2012-07-31 | $3.48M derived: sum of 4 quarters · filed 2013-12-03 |
| 2012-03-31 | $775.15K 10-Q · filed 2013-05-02 | $1.35M 10-Q · filed 2013-05-02 | $2.69M derived: sum of 3 quarters · filed 2013-12-03 | $2.63M derived: sum of 4 quarters · filed 2013-12-03 | ||
| 2011-12-31 | $579.31K 10-Q · filed 2013-01-30 | $1.92M derived: sum of 2 quarters · filed 2013-12-03 | $1.85M derived: sum of 3 quarters · filed 2013-12-03 | |||
| 2011-09-30 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-03 | $1.27M derived: sum of 2 quarters · filed 2013-12-03 | $973.75K 10-K · filed 2013-12-03 | |||
| 2011-06-30 | -$67.42K 10-Q · filed 2012-07-31 | -$364.73K 10-Q · filed 2012-07-31 | ||||
| 2010-09-30 | $1.09M 10-K · filed 2012-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |